Chapter 13: CNS Depressants & Muscle Relaxants

CNS Depressants & Muscle Relaxants pharmacology chapter details central nervous system (CNS) depressants, differentiating between sedatives, which reduce excitability without inducing sleep, and hypnotics, which actively cause sleep, frequently categorized together as sedative–hypnotics based on the administered dosage and patient response. The discussion encompasses the fundamental physiology of sleep, outlining the cyclical stages of Non–Rapid Eye Movement (NREM) and Rapid Eye Movement (REM) sleep, and explains how prolonged drug use can lead to REM interference and subsequent REM rebound upon cessation, causing daytime fatigue and vivid dreams, respectively. Nonpharmacological methods for managing sleep disorders are highly recommended as a crucial initial step prior to initiating drug therapy. Key drug categories covered include benzodiazepines, nonbenzodiazepines (such as zolpidem and zopiclone), and the older class, barbiturates. The primary mechanism of action for both benzodiazepines and barbiturates involves enhancing the activity of the brain's main inhibitory neurotransmitter, gamma-aminobutyric acid (GABA), thereby modulating CNS stimulation. Benzodiazepines, which suppress REM sleep less intensely than barbiturates, are frequently prescribed for short-term relief of anxiety, seizures, muscle spasms, and insomnia, offering a more favorable safety profile and a higher therapeutic index compared to the older drugs. Benzodiazepine overdose can be acutely reversed using the antidote flumazenil, while barbiturate toxicity requires comprehensive symptomatic and supportive care, often involving activated charcoal and urine alkalization. Critical safety considerations include recognizing the intensified CNS depression that occurs when these medications are combined with other depressants like alcohol or opioids, and monitoring for liver enzyme induction, a major interaction associated with barbiturates. Furthermore, the chapter examines muscle relaxants, which are primarily used to alleviate painful musculoskeletal conditions and are most effective when paired with rest and physiotherapy. Most muscle relaxants are centrally acting, except for dantrolene, which acts directly on muscle fibers by decreasing calcium release. The nursing process is extensively reviewed, stressing the importance of thorough baseline assessment, especially neurological status and substance use history, and developing a collaborative plan that prioritizes patient safety measures—such as preventing falls, monitoring for respiratory depression, ensuring gradual drug weaning, and educating patients about the risks of tolerance and dependency.